The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling

NCT06717295 · clinicaltrials.gov ↗

RECRUITING

Status

6000

Enrollment

INDUSTRY

Sponsor class

Conditions

Brest Cancer
Lung Cancer (NSCLC)
Pancreatic Cancer, Adult
Prostate Cancers
Ovarian Cancer
Colorectal Cancer
Glioblastoma (GBM)
Liver Carcinoma

Interventions

DIAGNOSTIC_TEST: DiNanoQ: A multi-cancer early detection (MCED) blood test
OTHER: DiNanoTrack: Therapeutic Response Monitoring Blood Test

Sponsor

Javier Toledo